2023 Q2 Form 10-Q Financial Statement

#000158067023000075 Filed on May 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $645.3M $487.4M
YoY Change -10.76% -10.75%
Cost Of Revenue $503.3M $388.5M
YoY Change 2.36% 0.23%
Gross Profit $141.9M $98.82M
YoY Change -38.65% -37.62%
Gross Profit Margin 22.0% 20.28%
Selling, General & Admin $76.85M $72.77M
YoY Change 6.22% 16.08%
% of Gross Profit 54.14% 73.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $505.0K $482.0K
YoY Change 32.2% 38.51%
% of Gross Profit 0.36% 0.49%
Operating Expenses $76.85M $72.77M
YoY Change 6.22% 16.08%
Operating Profit $65.09M $26.05M
YoY Change -59.07% -72.78%
Interest Expense $0.00 $0.00
YoY Change
% of Operating Profit 0.0% 0.0%
Other Income/Expense, Net $6.323M $6.297M
YoY Change 57.84% 64.41%
Pretax Income $71.41M $32.35M
YoY Change -56.19% -67.51%
Income Tax $18.28M $5.386M
% Of Pretax Income 25.59% 16.65%
Net Earnings $53.13M $26.96M
YoY Change -56.93% -65.73%
Net Earnings / Revenue 8.23% 5.53%
Basic Earnings Per Share $2.26 $1.15
Diluted Earnings Per Share $2.25 $1.14
COMMON SHARES
Basic Shares Outstanding 23.53M shares 23.31M shares
Diluted Shares Outstanding 23.61M shares 23.63M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $43.33M $42.97M
YoY Change 3.25% -19.43%
Cash & Equivalents $43.33M $42.97M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $2.754B $2.727B
Prepaid Expenses
Receivables $48.17M $21.87M
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.845B $2.791B
YoY Change 4.31% 14.53%
LONG-TERM ASSETS
Property, Plant & Equipment $42.79M $35.27M
YoY Change 110.65% 81.63%
Goodwill $12.02M $12.02M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $135.2M $153.9M
YoY Change
Other Assets $34.11M $31.55M
YoY Change -22.06% -25.06%
Total Long-Term Assets $294.2M $309.5M
YoY Change 102.07% 97.33%
TOTAL ASSETS
Total Short-Term Assets $2.845B $2.791B
Total Long-Term Assets $294.2M $309.5M
Total Assets $3.140B $3.101B
YoY Change 9.26% 19.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $59.37M $39.94M
YoY Change 47.81% 81.83%
Accrued Expenses $123.8M $114.4M
YoY Change 6.18% 27.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $201.5M $211.7M
YoY Change 8.66% 36.05%
LONG-TERM LIABILITIES
Long-Term Debt $1.189B $1.200B
YoY Change 2.87% 19.55%
Other Long-Term Liabilities $18.40M $15.21M
YoY Change -0.72% 23.97%
Total Long-Term Liabilities $1.207B $1.215B
YoY Change 2.81% 19.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $201.5M $211.7M
Total Long-Term Liabilities $1.207B $1.215B
Total Liabilities $1.409B $1.427B
YoY Change 3.61% 21.79%
SHAREHOLDERS EQUITY
Retained Earnings $1.771B $1.717B
YoY Change 13.07% 19.05%
Common Stock $275.0K $275.0K
YoY Change 1.48% 1.48%
Preferred Stock
YoY Change
Treasury Stock (at cost) $355.0M $355.0M
YoY Change 0.0% 11.79%
Treasury Stock Shares 3.939M shares
Shareholders Equity $1.731B $1.674B
YoY Change
Total Liabilities & Shareholders Equity $3.140B $3.101B
YoY Change 9.26% 19.53%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $53.13M $26.96M
YoY Change -56.93% -65.73%
Depreciation, Depletion And Amortization $505.0K $482.0K
YoY Change 32.2% 38.51%
Cash From Operating Activities $15.24M $77.60M
YoY Change -112.14% -156.32%
INVESTING ACTIVITIES
Capital Expenditures $195.0K $76.00K
YoY Change -107.65%
Acquisitions
YoY Change
Other Investing Activities -$1.792M -$4.779M
YoY Change 65.62% 1157.63%
Cash From Investing Activities -$1.987M -$4.855M
YoY Change 83.64% 253.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -12.88M -$61.78M
YoY Change -111.18% -143.51%
NET CHANGE
Cash From Operating Activities 15.24M $77.60M
Cash From Investing Activities -1.987M -$4.855M
Cash From Financing Activities -12.88M -$61.78M
Net Change In Cash 368.0K $10.97M
YoY Change -103.24% 290.18%
FREE CASH FLOW
Cash From Operating Activities $15.24M $77.60M
Capital Expenditures $195.0K $76.00K
Free Cash Flow $15.04M $77.52M
YoY Change -111.98% -156.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001580670
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-36126
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
LGI HOMES, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3088013
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1450 Lake Robbins Drive,
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 430,
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
The Woodlands,
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77380
CY2023Q1 dei City Area Code
CityAreaCode
(281)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
362-8998
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
LGIH
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23532734 shares
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42966000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31998000 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
21870000 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
25143000 usd
CY2023Q1 us-gaap Inventory Real Estate
InventoryRealEstate
2880520000 usd
CY2022Q4 us-gaap Inventory Real Estate
InventoryRealEstate
2898296000 usd
CY2023Q1 us-gaap Earnest Money Deposits
EarnestMoneyDeposits
26425000 usd
CY2022Q4 us-gaap Earnest Money Deposits
EarnestMoneyDeposits
25031000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
35273000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
32997000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
76724000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
93159000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
5127000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
6186000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
12018000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
12018000 usd
CY2023Q1 us-gaap Assets
Assets
3100923000 usd
CY2022Q4 us-gaap Assets
Assets
3124828000 usd
CY2023Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
39940000 usd
CY2022Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
25287000 usd
CY2023Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
340917000 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
340128000 usd
CY2023Q1 us-gaap Notes Payable
NotesPayable
1045837000 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
1117001000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1426694000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1482416000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27472206 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23532734 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27245278 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23305806 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
275000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
272000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
311525000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
306673000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1717451000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1690489000 usd
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
3939472 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
355022000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
355022000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1674229000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1642412000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3100923000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3124828000 usd
CY2023Q1 us-gaap Revenues
Revenues
487357000 usd
CY2022Q1 us-gaap Revenues
Revenues
546050000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
388541000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
387643000 usd
CY2023Q1 us-gaap Selling Expense
SellingExpense
42805000 usd
CY2022Q1 us-gaap Selling Expense
SellingExpense
34398000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29960000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28289000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
26051000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
95720000 usd
CY2023Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
6297000 usd
CY2022Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
3830000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32348000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
99550000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5386000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20864000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
26962000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
78686000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.15
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.30
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.14
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.25
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23381294 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23837170 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23629779 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24194321 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1642412000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
26962000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
206000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3103000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1546000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1674229000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1395848000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
78686000 usd
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
57659000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
294000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3570000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
2012000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1422751000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
26962000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
78686000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2245000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
178000 usd
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2425000 usd
CY2022Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
129000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
482000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
348000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1564000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3103000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3570000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-1059000 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-3264000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3273000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9420000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-15945000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
251612000 usd
CY2023Q1 us-gaap Increase Decrease In Earnest Money Deposits Outstanding
IncreaseDecreaseInEarnestMoneyDepositsOutstanding
1394000 usd
CY2022Q1 us-gaap Increase Decrease In Earnest Money Deposits Outstanding
IncreaseDecreaseInEarnestMoneyDepositsOutstanding
-1531000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-22290000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-362000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
14653000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7793000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-8953000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
10464000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
77600000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-137787000 usd
CY2023Q1 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
76000 usd
CY2022Q1 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
993000 usd
CY2023Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
5919000 usd
CY2022Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
380000 usd
CY2023Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
1140000 usd
CY2022Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4855000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1373000 usd
CY2023Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
32890000 usd
CY2022Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
197617000 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
105000000 usd
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
CY2023Q1 lgih Proceeds From Land Financing Arrangements
ProceedsFromLandFinancingArrangements
26885000 usd
lgih Proceeds From Land Financing Arrangements
ProceedsFromLandFinancingArrangements
0 usd
CY2023Q1 lgih Payments On Financing Arrangements
PaymentsOnFinancingArrangements
17886000 usd
lgih Payments On Financing Arrangements
PaymentsOnFinancingArrangements
0 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
212000 usd
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1546000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2013000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
57659000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-61777000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
141971000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10968000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2811000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31998000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50514000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42966000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53325000 usd
CY2023Q1 us-gaap Inventory Finished Homes
InventoryFinishedHomes
417575000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates, and these differences could have a significant impact on the financial statements.</span></div>
CY2023Q1 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1922275000 usd
CY2022Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1911307000 usd
CY2023Q1 us-gaap Inventory Operative Builders Other
InventoryOperativeBuildersOther
36636000 usd
CY2022Q4 us-gaap Inventory Operative Builders Other
InventoryOperativeBuildersOther
35074000 usd
CY2023Q1 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
350098000 usd
CY2022Q4 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
287069000 usd
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
57700000 usd
CY2022Q4 us-gaap Inventory Finished Homes
InventoryFinishedHomes
523054000 usd
CY2023Q1 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
2726584000 usd
CY2022Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
2756504000 usd
CY2023Q1 lgih Inventory Real Estate Not Owned
InventoryRealEstateNotOwned
153936000 usd
CY2022Q4 lgih Inventory Real Estate Not Owned
InventoryRealEstateNotOwned
141792000 usd
CY2023Q1 us-gaap Inventory Real Estate
InventoryRealEstate
2880520000 usd
CY2022Q4 us-gaap Inventory Real Estate
InventoryRealEstate
2898296000 usd
CY2023Q1 lgih Transfer Of Real Estate Inventory To Rental Properties
TransferOfRealEstateInventoryToRentalProperties
2700000 usd
CY2023Q1 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P1Y
CY2023Q1 lgih Land Financing Arrangements
LandFinancingArrangements
153936000 usd
CY2022Q4 lgih Land Financing Arrangements
LandFinancingArrangements
141792000 usd
CY2023Q1 lgih Real Estate Inventory Development And Construction Payable
RealEstateInventoryDevelopmentAndConstructionPayable
68239000 usd
CY2022Q4 lgih Real Estate Inventory Development And Construction Payable
RealEstateInventoryDevelopmentAndConstructionPayable
73678000 usd
CY2023Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
51071000 usd
CY2022Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
47037000 usd
CY2023Q1 lgih Inventory Related Obligations
InventoryRelatedObligations
12618000 usd
CY2022Q4 lgih Inventory Related Obligations
InventoryRelatedObligations
13039000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
8873000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
12900000 usd
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
11350000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
10750000 usd
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
7689000 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
10906000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6261000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
5545000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
5669000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
5182000 usd
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
15211000 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
19299000 usd
CY2023Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
340917000 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
340128000 usd
CY2023Q1 lgih Inventory Related Obligation Term
InventoryRelatedObligationTerm
P30Y
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
10750000 usd
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
7850000 usd
CY2023Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1852000 usd
CY2022Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2465000 usd
CY2023Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1252000 usd
CY2022Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1965000 usd
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
11350000 usd
CY2022Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
8350000 usd
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
2939472 shares
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
10404000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
11349000 usd
CY2023Q1 us-gaap Notes Payable
NotesPayable
1045837000 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
1117001000 usd
CY2023Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
19169000 usd
CY2022Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
7027000 usd
CY2023Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
19169000 usd
CY2022Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
7027000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
0 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
0 usd
CY2023Q1 us-gaap Interest Paid
InterestPaid
25500000 usd
CY2022Q1 us-gaap Interest Paid
InterestPaid
9668000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3100000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
700000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.167
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
100000 usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
400000 usd
CY2022Q1 lgih Stock Repurchase Program Additional Amount Authorized
StockRepurchaseProgramAdditionalAmountAuthorized
200000000 usd
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
550000000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2022Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
475055 shares
CY2023Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
211500000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
26962000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
78686000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23381294 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23837170 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
248485 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
357151 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23629779 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24194321 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.15
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.30
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.14
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.25
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24288 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27001 shares
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
1
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
5700000 usd
CY2023Q1 us-gaap Land Under Purchase Options Recorded
LandUnderPurchaseOptionsRecorded
24139000 usd
CY2022Q4 us-gaap Land Under Purchase Options Recorded
LandUnderPurchaseOptionsRecorded
22406000 usd
CY2023Q1 lgih Commitment Under Land Purchase Option And Deposit Agreement
CommitmentUnderLandPurchaseOptionAndDepositAgreement
439666000 usd
CY2022Q4 lgih Commitment Under Land Purchase Option And Deposit Agreement
CommitmentUnderLandPurchaseOptionAndDepositAgreement
411776000 usd
CY2023Q1 lgih Lots Under Purchase Options Recorded
LotsUnderPurchaseOptionsRecorded
12088
CY2022Q4 lgih Lots Under Purchase Options Recorded
LotsUnderPurchaseOptionsRecorded
13184
CY2023Q1 lgih Refundable Land Deposits Of Purchase Contractsof Finished Lots
RefundableLandDepositsOfPurchaseContractsofFinishedLots
12800000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5400000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4900000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
5200000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
600000 usd
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
500000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
500000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
400000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.057
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M6D
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1297000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1434000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1198000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1069000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
962000 usd
CY2023Q1 lgih Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
526000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6486000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
817000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
5669000 usd
CY2023Q1 lgih Lettersof Credit Surety Bondsand Other Financial Guarantees
LettersofCreditSuretyBondsandOtherFinancialGuarantees
361100000 usd
CY2022Q4 lgih Lettersof Credit Surety Bondsand Other Financial Guarantees
LettersofCreditSuretyBondsandOtherFinancialGuarantees
368100000 usd
CY2023Q1 us-gaap Payments To Acquire Limited Partnership Interests
PaymentsToAcquireLimitedPartnershipInterests
16000000 usd
us-gaap Payments To Acquire Limited Partnership Interests
PaymentsToAcquireLimitedPartnershipInterests
11200000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2200000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
200000 usd
CY2023Q1 us-gaap Revenues
Revenues
487357000 usd
CY2022Q1 us-gaap Revenues
Revenues
546050000 usd
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
7 business
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
5 home
CY2023Q1 us-gaap Revenues
Revenues
487357000 usd
CY2022Q1 us-gaap Revenues
Revenues
546050000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32348000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
99550000 usd
CY2023Q1 us-gaap Assets
Assets
3100923000 usd
CY2022Q4 us-gaap Assets
Assets
3124828000 usd

Files In Submission

Name View Source Status
lgih-20230331_def.xml Edgar Link unprocessable
0001580670-23-000075-index-headers.html Edgar Link pending
0001580670-23-000075-index.html Edgar Link pending
0001580670-23-000075.txt Edgar Link pending
0001580670-23-000075-xbrl.zip Edgar Link pending
a33123ex311.htm Edgar Link pending
a33123ex312.htm Edgar Link pending
a33123ex321.htm Edgar Link pending
a33123ex322.htm Edgar Link pending
ex101withexhibita.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lgih-20230331.htm Edgar Link pending
lgih-20230331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lgih-20230331_lab.xml Edgar Link unprocessable
lgih-20230331_cal.xml Edgar Link unprocessable
lgih-20230331_pre.xml Edgar Link unprocessable
lgih-20230331_htm.xml Edgar Link completed
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wfpicture.jpg Edgar Link pending